In summary, the epigenetic regulation of EZH2/PRC2 plays an important role in the progression of HNSCC and has clinical significance as a risk predictor for this disease and in molecular targeted therapy. The gene discussed is EZH2; the disease is head and neck squamous cell carcinoma.